|Docket No.||Op. Below||Argument||Opinion||Vote||Author||Term|
|15-1039||Fed. Cir.||Apr 26, 2017||Jun 12, 2017||9-0||Thomas||OT 2016|
Holding: Section 262(l)(2)(A) of the Biologics Price Competition and Innovation Act of 2009 is not enforceable by injunction under federal law, but the U.S. Court of Appeals for the Federal Circuit on remand should determine whether a state-law injunction is available; an applicant may provide notice of commercial marketing under Section 262(l)(8)(A) prior to obtaining licensure.
Judgment: Vacated in part, reversed in part, and remanded, 9-0, in an opinion by Justice Thomas on June 12, 2017. Justice Breyer filed a concurring opinion.
|Date||Proceedings and Orders |
|Dec 23 2015||Application (15A672) to extend the time to file a petition for a writ of certiorari from January 14, 2016 to February 16, 2016, submitted to The Chief Justice.|
|Dec 29 2015||Application (15A672) granted by The Chief Justice extending the time to file until February 16, 2016.|
|Feb 16 2016||Petition for a writ of certiorari filed. (Response due March 21, 2016)|
|Mar 21 2016||Brief amicus curiae of Biosimilars Council filed.|
|Mar 21 2016||Motion for leave to file amici brief filed by Apotex, Inc., et al.|
|Mar 21 2016||Brief amici curiae of Hospira, Inc, et al. filed.|
|Mar 21 2016||Brief of respondents Amgen Inc., et al. in opposition filed.|
|Mar 21 2016||Brief amicus curiae of Mylan, Inc. filed.|
|May 31 2016||DISTRIBUTED for Conference of June 16, 2016.|
|May 31 2016||Reply of petitioner Sandoz Inc. filed. (Distributed)|
|Jun 20 2016||The Solicitor General is invited to file a brief in this case expressing the views of the United States.|
|Dec 7 2016||Brief amicus curiae of United States filed. VIDED.|
|Dec 20 2016||Supplemental brief of respondents Amgen Inc., et al. filed. VIDED.|
|Dec 21 2016||DISTRIBUTED for Conference of January 6, 2017.|
|Jan 9 2017||DISTRIBUTED for Conference of January 13, 2017.|
|Jan 13 2017||Petition GRANTED. The petition for a writ of certiorari in No. 15-1195 is granted. The cases are consolidated and a total of one hour is allotted for oral argument.|
|Jan 13 2017||Motion for leave to file amici brief filed by Apotex, Inc., et al. GRANTED.|
|Jan 25 2017||The following briefing schedule is adopted: Petitioner in No. 15-1039 will file an opening brief limited to the question presented in its petition, not to exceed 15,000 words, on or before Friday, February 10, 2017. Petitioners in No. 15-1195 will file a consolidated opening brief on the question presented in their petition and response brief, not to exceed 19,000 words, on or before Friday, March 10, 2017. Petitioner in No. 15-1039 will file a consolidated response brief and reply brief, not to exceed 10,000 words, on or before Friday, March 31, 2017. Petitioners in No. 15-1195 will file a reply brief, not to exceed 6,000 words, on or before Friday, April 14, 2017. Any brief of an amicus curiae in support of petitioner in No. 15-1039 or in support of neither party is to be filed on or before Friday, February 17, 2017, and the brief should bear a light green cover. Any brief of an amicus curiae in support of petitioners in No. 15-1195 is to be filed on or before Friday, March 17, 2017, and the brief should bear a dark green cover. An amicus curiae may file only a single brief in these cases. VIDED.|
|Jan 30 2017||Joint motion of the parties to dispense with printing the joint appendix filed. VIDED.|
|Feb 10 2017||Brief of petitioner Sandoz Inc. filed.|
|Feb 17 2017||SET FOR ARGUMENT ON Wednesday, April 26, 2017. VIDED.|
|Feb 17 2017||Brief amicus curiae of Adello Biologics, LLC filed.|
|Feb 17 2017||Brief amici curiae of Pharmaceutical Care Management Association, et al. filed.|
|Feb 17 2017||Brief amici curiae of Apotex Inc. and Apotex Corp. filed. VIDED.|
|Feb 17 2017||Brief amicus curiae of Biosimilars Council filed. VIDED.|
|Feb 17 2017||Brief amicus curiae of America's Health Insurance Plans filed. VIDED.|
|Feb 17 2017||Brief amicus curiae of United States filed. VIDED.|
|Feb 17 2017||Brief amici curiae of AARP Foundation, et al. filed.|
|Feb 17 2017||Brief amicus curiae of Coherus Biosciences, Inc. filed. VIDED.|
|Feb 17 2017||Brief amicus curiae of Mylan, Inc. filed. VIDED.|
|Feb 21 2017||Motion to dispense with printing the joint appendix filed by petitioners GRANTED. VIDED|
|Feb 24 2017||Record requested from the U.S.C.A. for the Federal Circuit. VIDED.|
|Mar 10 2017||Opening and Response Brief for Amgen Inc., et al. filed. VIDED.|
|Mar 17 2017||Brief amicus curiae of AbbeVie Inc. filed. VIDED.|
|Mar 17 2017||Motion of the Acting Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument filed. VIDED.|
|Mar 17 2017||Brief amicus curiae of Janssen Biotech, Inc. filed. VIDED.|
|Mar 17 2017||Brief amicus curiae of Biotechnology Innovation Organization filed. VIDED.|
|Mar 17 2017||Brief amicus curiae of Genentech, Inc. filed. VIDED.|
|Mar 22 2017||CIRCULATED.|
|Mar 27 2017||Record received from the U.S.C.A. for the Federal Circuit. The record is available on PACER, except for confidential materials transmitted separately. VIDED.|
|Mar 31 2017||Consolidated Response and Reply Brief for Sandoz Inc. Filed. (Distributed) VIDED.|
|Apr 13 2017||Motion of the Acting Solicitor General for leave to participate in oral argument as amici curiae and for divided argument GRANTED. VIDED. Justice Gorsuch too no part in the consideration or decision of this motion.|
|Apr 26 2017||Argued. For petitioner in No. 15-1039: Deanne E. Maynard, Washington, D. C.; and Anthony A. Yang, Assistant to the Solicitor General, Department of Justice, Washington, D. C. (for United States, as amicus curiae.) For petitioners in 15-1195: Seth P. Waxman, Washington, D. C. VIDED.|
|Jun 12 2017||Adjudged to be VACATED IN PART, REVERSED IN PART, and case REMANDED. Thomas, J., delivered the opinion for a unanimous Court. Breyer, J., filed a concurring opinion. VIDED.|
|Jul 14 2017||JUDGMENT ISSUED.|
In 2019, the Supreme Court limited the scope of a federal law that bans people convicted of felonies from having a gun. Up this morning at the court: back-to-back cases that will decide how many felon-in-possession convictions will need new trials or pleas under that 2019 ruling.
NEW: SCOTUS adds one new case to its docket for next term: Hemphill v. New York, a criminal-procedure case about the interaction between hearsay rules and the right of defendants to confront witnesses against them. Still no action on major petitions involving guns and abortion.
The court will release orders at 9:30 a.m. EDT followed by oral argument in two cases.
First, whether Alaska Native regional and village corporations are “Indian Tribes” for purposes of CARES Act Covid-related relief.
By @StanfordLaw’s Gregory Ablavsky.
Are Alaska Native corporations Indian tribes? A multimillion-dollar question - SCOTUSblog
Are Alaska Native corporations — special corporations that Congress created in 1971 when it resolved Native claims ...
It's official: In the first-ever SCOTUS bracketology tournament, our readers have chosen CHIEF JUSTICE EARL WARREN as the greatest justice in history. The author of Brown v. Board, Loving v. Virginia, and Miranda v. Arizona defeated top-seeded John Marshall in the final round.
We've reached the final round of SCOTUS bracketology, and two illustrious chief justices are facing off for the championship. One wrote Marbury v. Madison. The other wrote Brown v. Board. Our full write-up on both finalists is here: https://www.scotusblog.com/2021/04/the-great-chief-and-the-super-chief-a-final-showdown-in-supreme-court-march-madness/
Cast your vote below!
NEW: The Supreme Court will issue opinion(s?) next Thursday April 22. We’re still waiting on decisions in the ACA case and Fulton v. City of Philadelphia about religious liberty and LGBT rights.
Four Democrats unveiled legislation today to expand the size of the Supreme Court from nine justices to 13 -- but Democratic leaders in both the House and Senate quickly threw cold water on the proposal.
Here's our report from @jamesromoser:
Bill to enlarge the Supreme Court faces dim prospects in Congress - SCOTUSblog
Four congressional Democrats introduced legislation Thursday to expand the number of seats on the Supreme Court from ...
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.